Clinical efficacy of oral administration of 200 mg gatifloxacin once daily for 3 days for the treatment of patients with uncomplicated cystitis

Journal of Infection and Chemotherapy

Volumn 15, Issue 2, 2009, Pages 104-107

  Yamamoto, Shingo ^a   Akiyama, Kikuo ^b   Yoshimoto, Tetsuro ^c   Kanokogi, Mototsugu ^d   Yabumoto, Hidenori ^e   Ihara, Hideari ^f   Ishikawa, Eiji ^g   Yoshioka, Masaru ^h   Kokura, Koji ⁱ   Shima, Hiroki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Akiyama Urological Clinic   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^d Kanokogi Urological Clinic   (Japan)

^e Department of Surgery Meiwa Hospital   (Japan)

^f Ihara Clinic   (Japan)

^g Ishikawa Clinic   (Japan)

^h Yoshioka Urological Clinic   (Japan)

ⁱ Takarazuka City Hospital   (Japan)

Author keywords

Clinical efficacy; Gatifloxacin; Uncomplicated cystitis

Indexed keywords

ANTIBIOTIC AGENT; GATIFLOXACIN; QUINOLONE DERIVATIVE;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MICTURITION; PATHOGENESIS; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION;

EID: 65349132055     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0671-2     Document Type: Article

References (10)

1. J.W. Warren E. Abrutyn J.R. Hebel J.R. Johnson A.J. Schaeffer W.E. Stamm 1999 Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 29 745 758
2. A.D. Tice 1999 Short-course therapy of acute cystitis: a brief review of therapeutic strategies J Antimicrob Chemother 43 SupplA 85 93 (Pubitemid 29123506)
3. C.M. Perry D. Ormrod M.O. Hurst 2002 Gatifloxacin: a review of its use in the management of bacterial infections Drugs 62 169 207 (Pubitemid 34169430)
4. K.G. Naber D.M. Allin L. Clarysse D.A. Haworth I.G. James C. Raini 2004 Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections Int J Antimicrob Agents 23 596 605 (Pubitemid 38759676)
5. G. Kahlmeter P. Menday 2003 Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections J Antimicrob Chemother 52 128 131 (Pubitemid 36850099)
6. M. Gobernado L. Valdés J.I. Alós C. García-Rey R. Dal-Ré J. Garca-de-Lomas 2007 Spanish Surveillance Group for Urinary Pathogens: Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain Rev Esp Quimioter 20 68 76
7. G.G. Zhanel T.L. Hisanaga N.M. Laing M.R. DeCorby K.A. Nichol B. Weshnoweski 2006 Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) Int J Antimicrob Agents 27 468 475 (Pubitemid 44236020)
8. Y. Kumamoto T. Tsukamoto M. Matsukawa Y. Kunishima T. Hirose S. Shigeta 2006 Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution Jpn J Antibiot 59 177 200 (Pubitemid 44098196)
9. G.A. Richard C.P. Mathew J.M. Kirstein D. Orchard J.Y. Yang 2002 Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens Urology 59 334 339 (Pubitemid 34189729)
10. S.A. Ferry S.E. Holm H. Stenlund R. Lundholm T.J. Monsen 2004 The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study Scand J Infect Dis 36 296 301 (Pubitemid 38714183)